Cutera, Inc. (CUTR)’s Stock Is Buy After Today’s Big Increase

February 15, 2018 - By reb123z

Investors sentiment decreased to 1.13 in Q3 2017. Its down 1.09, from 2.22 in 2017Q2. It fall, as 10 investors sold Cutera, Inc. shares while 43 reduced holdings. 30 funds opened positions while 30 raised stakes. 11.40 million shares or 1.35% less from 11.56 million shares in 2017Q2 were reported.
State Street invested in 214,028 shares or 0% of the stock. Cubist Systematic Strategies Limited Liability Corporation has invested 0.02% of its portfolio in Cutera, Inc. (NASDAQ:CUTR). Rice Hall James Assocs Ltd Liability accumulated 50,441 shares or 0.09% of the stock. Peak6 Invs L P reported 64,895 shares stake. Partner Invest L P holds 4,349 shares or 0.17% of its portfolio. California Pub Employees Retirement reported 0% of its portfolio in Cutera, Inc. (NASDAQ:CUTR). Citigroup accumulated 6,136 shares or 0% of the stock. Bogle Investment Management Limited Partnership De owns 0.29% invested in Cutera, Inc. (NASDAQ:CUTR) for 104,474 shares. 11,981 were accumulated by Perceptive Ltd Liability Com. Gsa Limited Liability Partnership accumulated 37,900 shares. Gabelli Funds Ltd Liability Com reported 0.09% stake. Meeder Asset Mngmt owns 22 shares. Argent Capital Ltd Liability Corporation invested in 0.05% or 31,925 shares. Thompson Davis & Incorporated reported 300 shares. 46,197 were accumulated by Products Prns Limited Com.

Since August 15, 2017, it had 0 insider purchases, and 11 insider sales for $1.87 million activity. APFELBERG DAVID B sold 1,000 shares worth $38,450. 7,175 Cutera, Inc. (NASDAQ:CUTR) shares with value of $325,386 were sold by Reinstein James A.. 2,947 Cutera, Inc. (NASDAQ:CUTR) shares with value of $100,198 were sold by SANTILLI RONALD J. Laber Larry also sold $264,980 worth of Cutera, Inc. (NASDAQ:CUTR) shares. 4,000 shares were sold by OShea Timothy J, worth $156,840.

The stock of Cutera, Inc. (NASDAQ:CUTR) is a huge mover today! The stock increased 8.15% or $3.8 during the last trading session, reaching $50.45. About 327,266 shares traded or 21.62% up from the average. Cutera, Inc. (NASDAQ:CUTR) has risen 102.00% since February 15, 2017 and is uptrending. It has outperformed by 85.30% the S&P500.
The move comes after 7 months positive chart setup for the $698.99 million company. It was reported on Feb, 15 by Barchart.com. We have $51.96 PT which if reached, will make NASDAQ:CUTR worth $20.97M more.

Cutera, Inc. (NASDAQ:CUTR) Ratings Coverage

Among 3 analysts covering Cutera (NASDAQ:CUTR), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cutera had 8 analyst reports since January 4, 2017 according to SRatingsIntel. The rating was maintained by Maxim Group on Wednesday, January 4 with “Buy”. Gabelli maintained the stock with “Buy” rating in Tuesday, June 27 report. The firm earned “Buy” rating on Tuesday, August 8 by Roth Capital. The stock has “Buy” rating by Maxim Group on Tuesday, August 8. The stock has “Buy” rating by Roth Capital on Tuesday, September 12. The rating was maintained by Gabelli with “Buy” on Wednesday, August 9. The firm earned “Buy” rating on Thursday, July 13 by Maxim Group.

More news for Cutera, Inc. (NASDAQ:CUTR) were recently published by: Globenewswire.com, which released: “Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial …” on February 14, 2018. Globenewswire.com‘s article titled: “Cutera Showcases Expanded Portfolio at AAD” and published on February 15, 2018 is yet another important article.

Cutera, Inc., a medical device company, designs, develops, makes, markets, and services laser and other energy based aesthetics systems worldwide. The company has market cap of $698.99 million. The firm offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It has a 67.09 P/E ratio. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.